OnKure Therapeutics

Precision oncology company developing novel, highly selective PI3Kα inhibitors designed to overcome resistance mechanisms and provide better outcomes for cancer patients.

Location
Boulder, Colorado, USA
Founded
2019
Investors
1
Categories
biotech, oncology, pi3k-inhibitors, targeted-therapy

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34